HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent ''direct'' effects on atherosclerotic vessels in high cholesterol diet-fed rabbits

Author： Mitani H.   Egashira K.   Kimura M.  

Publisher： Elsevier

ISSN： 1043-6618

Source： Pharmacological Research, Vol.48, Iss.5, 2003-11, pp. : 417-427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

HMG-CoA Reductase Inhibitor (Statin) Therapy and Coronary Atherosclerosis in Japanese Subjects: Role of High-Density Lipoprotein Cholesterol

By Tani Shigemasa   Nagao Ken   Hirayama Atsushi  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 411-417

Adis International

Access to resources Recommend Favorite

EFFECT OF THE NEW HMG-CoA REDUCTASE INHIBITOR CERIVASTATIN (BAY W 6228) ON MIGRATION, PROLIFERATION AND CHOLESTEROL SYNTHESIS IN ARTERIAL MYOCYTES

By Corsini A.   Arnaboldi L.   Raiteri M.   Quarato P.   Faggiotto A.   Paoletti R.   Fumagalli R.  

Pharmacological Research, Vol. 33, Iss. 1, 1996-01 ,pp. : 55-61

Academic Press

Access to resources Recommend Favorite

Comparison of the Cholesterol-Lowering Effects and Toxicity of D-003 and Lovastatin in Normocholesterolaemic Rabbits

By Gámez R.  

Drugs in R&D, Vol. 4, Iss. 4, 2003-01 ,pp. : 219-229

Adis International

Access to resources Recommend Favorite

Assessing Lipid Lowering and Plasma Cholesteryl Ester Transfer Protein Activity of Simvastatin Following Administration to Rabbits Fed a High Fat/Cholesterol Diet

By Risovic Verica   Man Damen   Sivak Olena   Lee Stephen   Wasan Kishor  

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 5, 2006-07 ,pp. : 609-615

Informa Healthcare

Access to resources Recommend Favorite

Cholesterol-Lowering

By  

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 113-113

Bentham Science Publishers

Access to resources Recommend Favorite